Here are the 10-K annual reports from OPGEN INC (OPGN) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow OPGN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OPGN filings page.
CapForce Inc. files its annual report describing a full pivot from infectious disease diagnostics to a capital-markets-focused financial technology model. The company now offers listing sponsorship and consultancy services for Asian growth companies targeting IPOs and direct listings and is developing a digital investment banking and cap table platform.
In 2025 CapForce acquired Sun Investment Enterprises Limited, owner of Malaysian fintech iCapX, to anchor its cap table management and data analytics capabilities. Control shifted to AEI Capital Ltd., which owns about 76.1% of the common stock, while non-affiliates held voting stock with a market value of about $11.6 million at $4.78 per share as of June 30, 2025.
The business is in an early stage, with only one advisory client, minimal headcount, and operations concentrated in Malaysia and Singapore. The filing highlights numerous risks, including heavy reliance on a single client, complex multi-jurisdictional regulation, cybersecurity and data-privacy exposure, low trading liquidity on the OTC Expert Market, and potential dilution from outstanding warrants and stock options.